Cardinal Health recalls 27M syringes

Cardinal Health revised its product correction for more than 27 million syringes on Feb 2, and the FDA upgraded the notice to a Class I recall — the most serious type.

Advertisement

Because of a change in manufacturing and rebranding, the syringes have different dimensions and were made by a new contract manufacturer. 

“The dimensional changes made to the Cardinal Health Monoject syringes, when used with syringe pumps, PCA pumps or enteral syringe pumps, may result in recognition, compatibility, and pump performance issues, such as overdose, underdose, delay in therapy, delay in occlusion alarms, and delay in feeding,” the FDA said. 

The latest update reports there have been zero deaths reported, but it does not mention any other adverse events.

In late 2023, the FDA opened an investigation into China-made plastic syringes because of reports of incompatibilities, with products breaking and leaking. 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

  • Abbott has launched an updated version of its Oncodetect blood test, which helps clinicians determine whether cancer remains in patients…

  • Becker’s asked supply chain leaders: If you had an extra $1 million for your supply chain budget, where would it…

  • As hospitals redefine the role of supply chain leaders to focus on enterprise strategy, digital transformation and resilience, health systems…

Advertisement

Comments are closed.